(2025)
Targeting protein kinase C-α prolongs survival and restores liver function in sepsis: evidence from preclinical models.
Pharmacol Res
[Epub ahead of print]
Prof. Dr. Gianni Panagiotou
Microbiome Dynamics · Leitung +49 3641 532-1759 gianni.panagiotou@leibniz-hki.deCurriculum vitae
Forschungsschwerpunkte
- Medizinische & Umweltmetagenomik: Mensch, Maus, Pflanzen, marine Lebewesen
- Systembiologie: Integration von –omics-Daten; Molekül/ Protein & Protein/ Protein Netzwerke
- Synthetische Biologie: Metabolische Modellierung auf Genomausmaß, Design von Probiotika, Entdeckung von Postbiotika
Publikationen
(2024)
tRNA hypomodification facilitates 5-fluorocytosine resistance via cross-pathway control system activation in Aspergillus fumigatus
Nucleic Acids Res ,
1-20.
(2024)
Distinct changes in serum metabolites and lipid species in the onset and progression of NAFLD in obese Chinese.
Comput Struct Biotechnol J 23(2024),
791-800.
(2024)
The human gut mycobiome and its potential as a regulator of the host’s metabolic health.
In: Brakhage AA, Kniemeyer O, Zipfel PF (eds.) The Mycota - Human and Animal Relationships 3. 6, pp. 121-133. Springer, Cham.
ISBN: 978-3-031-64852. (Review)
(2024)
FungiFun3: systemic gene set enrichment analysis for fungal species.
Bioinformatics 40(11),
btae620.
(2024)
Risk assessment with gene expression markers in sepsis development.
Cell Rep Med 5(9),
101712.
(2024)
In-vitro influence of specific Bacteroidales strains on gut and liver health related to Metabolic dysfunction-associated fatty liver disease.
Probiotics Antimicrob Proteins
[Epub ahead of print]
(2024)
Saccharomyces boulardii enhances anti-inflammatory effectors and AhR activation via metabolic interactions in probiotic communities.
ISME Journal 18(1),
wrae212.
(2024)
CD56-mediated activation of human natural killer cells is triggered by Aspergillus fumigatus galactosaminogalactan.
PLOS Pathog 20(6),
e1012315.
(2024)
Deep phenotyping of patients with MASLD upon high-intensity interval training.
JHEP Reports ,